30 9月 2024 by admin in UncategorizedComments Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
18 9月 2024 by admin in UncategorizedComments Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
10 9月 2024 by admin in UncategorizedComments Adcentrx Therapeutics Announces Formation of Scientific Advisory Board
03 9月 2024 by admin in UncategorizedComments Avenzo Therapeutics Announces Clinical Study Collaboration with Gilead Sciences to Evaluate AVZO-021 and Trodelvy® in HR+/HER2- Metastatic Breast Cancer
20 8月 2024 by admin in UncategorizedComments 国际著名骨髓瘤专家 Kenneth C. Anderson 教授和 Shaji Kumar 教授加入原 启生物科学顾问委员会
19 8月 2024 by admin in UncategorizedComments Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
08 8月 2024 by admin in UncategorizedComments Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
15 7月 2024 by admin in UncategorizedComments Eluminex Biosciences Announces First Patient Dosed in the Phase 1b LOTUS Trial of the Novel Trispecific Fusion Antibody EB-105 in Diabetic Macular Edema (DME)
